Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
Status:
Recruiting
Trial end date:
2023-07-05
Target enrollment:
Participant gender:
Summary
To explore triheptanoin (C7 oil) compatibility with the ketogenic diet by evaluating EEG, and
seizure rate, glycemia and ketosis in proven G1D patients receiving a ketogenic diet.
Phase:
Phase 2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)